GlassScriptPhysician profile
Xuemei Ye
NPI 1376937201
$1,296.89
in general payments reported to CMS, 2019-2025
25 companies · $28.95 in 2025
The $28.95 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $602 · 2021: $234 · 2022: $19.83 · 2025: $28.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $271.75 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $130.86 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.48 | 2019-2020 | |
| Glaxosmithkline, LLC. | $83.22 | 2020-2021 | |
| Celgene Corporation | $68.48 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $62.98 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $57.22 | 2019-2022 | |
| Genentech USA, INC. | $43.45 | 2019 | |
| Epizyme, INC. | $43.39 | 2020 | |
| Puma Biotechnology, INC. | $41.43 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $41.24 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $40.65 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $36.49 | 2019-2020 | |
| Array Biopharma INC | $36.27 | 2019-2021 | |
| Exelixis INC. | $35.77 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $28.95 | 2025 | Xospata |
| Seagen INC. | $28.30 | 2019 | |
| Kite Pharma, INC. | $26.44 | 2020 | |
| Abbvie INC. | $23.46 | 2020 | |
| Incyte Corporation | $20.82 | 2021 | |
| Genzyme Corporation | $20.46 | 2021 | |
| Eisai INC. | $13.50 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.49 | 2019 | |
| Emd Serono, INC. | $12.71 | 2019 | |
| Secura Bio, INC. | $7.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xuemei Ye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.